268 related articles for article (PubMed ID: 22230579)
1. Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.
Lekcharoensuk P; Wiriyarat W; Petcharat N; Lekcharoensuk C; Auewarakul P; Richt JA
Vaccine; 2012 Feb; 30(8):1453-9. PubMed ID: 22230579
[TBL] [Abstract][Full Text] [Related]
2. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
[TBL] [Abstract][Full Text] [Related]
3. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
[TBL] [Abstract][Full Text] [Related]
4. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken.
Bhatia S; Khandia R; Sood R; Bhat S; Siddiqui A; Jahagirdhar G; Mishra S; Mishra A; Pateriya AK; Kulkarni DD
Microb Pathog; 2016 Aug; 97():172-7. PubMed ID: 27296706
[TBL] [Abstract][Full Text] [Related]
5. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
6. Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.
Isakova-Sivak I; Chen LM; Bourgeois M; Matsuoka Y; Voeten JT; Heldens JG; van den Bosch H; Klimov A; Rudenko L; Cox NJ; Donis RO
Clin Vaccine Immunol; 2014 May; 21(5):722-31. PubMed ID: 24648485
[TBL] [Abstract][Full Text] [Related]
7. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
Dong J; Matsuoka Y; Maines TR; Swayne DE; O'Neill E; Davis CT; Van-Hoven N; Balish A; Yu HJ; Katz JM; Klimov A; Cox N; Li DX; Wang Y; Guo YJ; Yang WZ; Donis RO; Shu YL
Influenza Other Respir Viruses; 2009 Nov; 3(6):287-95. PubMed ID: 19903211
[TBL] [Abstract][Full Text] [Related]
8. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
9. Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza.
Jang JW; Lee CY; Kim IH; Choi JG; Lee YJ; Yuk SS; Lee JH; Song CS; Kim JH; Kwon HJ
J Vet Sci; 2017 Aug; 18(S1):299-306. PubMed ID: 28859269
[TBL] [Abstract][Full Text] [Related]
10. [Engineering by reverse genetics and characterization of the new reassortant influenza virus strain H5N1].
Zeberezhnyĭ AD; Grebennikova TV; Vorkunova GK; Yuzhakov AG; Kostina LV; Norkina SN; Aliper TI; Nepoklonov EA; Lvov DK
Vopr Virusol; 2014; 59(6):23-7. PubMed ID: 25929032
[TBL] [Abstract][Full Text] [Related]
11. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
[TBL] [Abstract][Full Text] [Related]
12. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens.
Li C; Ping J; Jing B; Deng G; Jiang Y; Li Y; Tian G; Yu K; Bu Z; Chen H
Biochem Biophys Res Commun; 2008 Jul; 372(2):293-7. PubMed ID: 18501701
[TBL] [Abstract][Full Text] [Related]
13. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a high-yield attenuated vaccine strain wholly derived from avian influenza viruses by use of reverse genetics.
Liu M; Liu CG; Zhang Y; Shi WL; Wang W; Liu YY
Vet Microbiol; 2012 Dec; 161(1-2):43-8. PubMed ID: 22832374
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
17. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
18. Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
Medina J; Boukhebza H; De Saint Jean A; Sodoyer R; Legastelois I; Moste C
Vaccine; 2015 Aug; 33(35):4221-7. PubMed ID: 26206270
[TBL] [Abstract][Full Text] [Related]
19. Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes.
Rajesh Kumar S; Chelvaretnam S; Tan Y; Prabakaran M
Viruses; 2017 Dec; 10(1):. PubMed ID: 29295514
[TBL] [Abstract][Full Text] [Related]
20. Application of reverse genetics for producing attenuated vaccine strains against highly pathogenic avian influenza viruses.
Uchida Y; Takemae N; Saito T
J Vet Med Sci; 2014 Aug; 76(8):1111-7. PubMed ID: 24805906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]